All Stories

  1. Identification of active compounds as novel dipeptidyl peptidase-4 inhibitors through machine learning and structure-based molecular docking simulations
  2. Therapeutic Applications of Ginseng Natural Compounds for Health Management
  3. natural compounds for skeletal muscle-associated metabolic disorders
  4. Extracellular matrix and skeletal muscle regeneration
  5. Virtual Insights into Natural Compounds as Potential 5α-Reductase Type II Inhibitors: A Structure-Based Screening and Molecular Dynamics Simulation Study
  6. Potential of Natural Phenolic Compounds as Antimicrobial Agents against Multidrug-Resistant Staphylococcus aureus in Chicken Meat
  7. Mss51 protein inhibition serves as a novel target for type 2 diabetes: a molecular docking and simulation study
  8. Therapeutic applications of ginseng for skeletal muscle-related disorder management
  9. Editorial: An insight into multi-omics analysis of dementia disorders
  10. Editorial: Impact of hyperglycemia induced oxidative stress in genetics and epigenetics of metabolic diseases
  11. The roles of growth factors and hormones in the regulation of muscle satellite cells for cultured meat production
  12. IgLON4 Regulates Myogenesis via Promoting Cell Adhesion and Maintaining Myotube Orientation
  13. Dipeptidyl peptidase-4 inhibitory potentials of Glycyrrhiza uralensis and its bioactive compounds licochalcone A and licochalcone B: An in silico and in vitro study
  14. Editorial: Unfolded protein response (UPR): An impending target for multiple neurological disorders
  15. Identification and Evaluation of Traditional Chinese Medicine Natural Compounds as Potential Myostatin Inhibitors: An In Silico Approach
  16. Myostatin and its Regulation: A Comprehensive Review of Myostatin Inhibiting Strategies
  17. Biocomputational Assessment of Natural Compounds as a Potent Inhibitor to Quorum Sensors in Ralstonia solanacearum
  18. Molecular Mechanisms and Current Treatment Options for Cancer Cachexia
  19. MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
  20. Extracellular Matrix and the Production of Cultured Meat
  21. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein
  22. Fruit Derived Potentially Bioactive Bioengineered Silver Nanoparticles
  23. Cell Types Used for Cultured Meat Production and the Importance of Myokines
  24. Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy
  25. Computational Identification of Dithymoquinone as a Potential Inhibitor of Myostatin and Regulator of Muscle Mass
  26. Interaction of Fibromodulin and Myostatin to Regulate Skeletal Muscle Aging: An Opposite Regulation in Muscle Aging, Diabetes, and Intracellular Lipid Accumulation
  27. Halotolerant Microbial Consortia for Sustainable Mitigation of Salinity Stress, Growth Promotion, and Mineral Uptake in Tomato Plants and Soil Nutrient Enrichment
  28. A Comprehensive Review and Perspective on Natural Sources as Dipeptidyl Peptidase-4 Inhibitors for Management of Diabetes
  29. Biocomputational Screening of Natural Compounds against Acetylcholinesterase
  30. Identification of Novel FNIN2 and FNIN3 Fibronectin-Derived Peptides That Promote Cell Adhesion, Proliferation and Differentiation in Primary Cells and Stem Cells
  31. IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
  32. Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs
  33. Isolation and Characterization of Compounds from Glycyrrhiza uralensis as Therapeutic Agents for the Muscle Disorders
  34. Consequences of Dicarbonyl Stress on Skeletal Muscle Proteins in Type 2 Diabetes
  35. Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases
  36. Skeletal Muscle Extracellular Matrix: Composition, Structure and Function
  37. Expedition into Taurine Biology: Structural Insights and Therapeutic Perspective of Taurine in Neurodegenerative Diseases
  38. Implications of Skeletal Muscle Extracellular Matrix Remodeling in Metabolic Disorders: Diabetes Perspective
  39. Study of Caspase 8 Inhibition for the Management of Alzheimer’s Disease: A Molecular Docking and Dynamics Simulation
  40. Cross-Talk Between Extracellular Matrix and Skeletal Muscle: Implications for Myopathies
  41. N-Acetylaspartate Is an Important Brain Osmolyte
  42. Understanding Calcium-Dependent Conformational Changes in S100A1 Protein: A Combination of Molecular Dynamics and Gene Expression Study in Skeletal Muscle
  43. An insight into molecular interaction of PGIP with PG for banana cultivar
  44. Correction: Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro
  45. Pharmacophore-based approaches in the rational repurposing technique for FDA approved drugs targeting SARS-CoV-2 Mpro
  46. Transthyretin Maintains Muscle Homeostasis Through the Novel Shuttle Pathway of Thyroid Hormones During Myoblast Differentiation
  47. Targeting integrins for cancer management using nanotherapeutic approaches: Recent advances and challenges
  48. Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance
  49. Targeting Caspase 8: Using Structural and Ligand-Based Approaches to Identify Potential Leads for the Treatment of Multi-Neurodegenerative Diseases
  50. Subtractive genomics approach for identification of putative antimicrobial targets in Xanthomonas oryzae pv. oryzae KACC10331
  51. Dermatopontin in Skeletal Muscle Extracellular Matrix Regulates Myogenesis
  52. Lead Optimization Resources in Drug Discovery for Diabetes
  53. Efficacy of a novel bacteriocin isolated from Lysinibacillus sp. against Bacillus pumilus
  54. Multi-Spectroscopic Characterization of Human Serum Albumin Binding with Cyclobenzaprine Hydrochloride: Insights from Biophysical and In Silico Approaches
  55. NeuroMuscleDB: a Database of Genes Associated with Muscle Development, Neuromuscular Diseases, Ageing, and Neurodegeneration
  56. Protein modeling, molecular network and molecular dynamics study of newly sequenced interleukin-18 (IL-18) gene in Mus musculus
  57. Computational Analysis of Protein–Protein Interactions in Motile T-Cells
  58. Biogenic pentagonal silver nanoparticles for safer and more effective antibacterial therapeutics
  59. A complex relationship between extracellular matrix, insulin resistance, and skeletal muscle
  60. Nanoparticle-Based Drugs: A Potential Armamentarium of Effective Anti-Cancer Therapies
  61. A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
  62. Novel insight into the molecular interaction of catalase and sucrose: A combination of in silico and in planta assays study
  63. ADNCD: a compendious database on anti-diabetic natural compounds focusing on mechanism of action
  64. Protein-protein Interactions and their Role in Various Diseases and their Prediction Techniques
  65. Peptide based therapeutics and their use for the treatment of neurodegenerative and other diseases
  66. Computer Aided Drug Design and its Application to the Development of Potential Drugs for Neurodegenerative Disorders
  67. Role of Azoles in Cancer Prevention and Treatment: Present and Future Perspectives
  68. Binding of Tolperisone Hydrochloride with Human Serum Albumin: Effects on the Conformation, Thermodynamics, and Activity of HSA
  69. Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
  70. Fibromodulin and regulation of the intricate balance between myoblast differentiation to myocytes or adipocyte-like cells
  71. Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy
  72. Do all roads lead to the Rome? The glycation perspective!
  73. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview
  74. Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds
  75. Gymnema sylvestre for Diabetes: From Traditional Herb to Future’s Therapeutic
  76. Genome-wide comparative analysis of codon usage bias and codon context patterns among cyanobacterial genomes
  77. Identification of common therapeutic targets for selected neurodegenerative disorders: An in silico approach
  78. Computer Aided Drug Design: Success and Limitations
  79. Implication of Caspase-3 as a Common Therapeutic Target for Multineurodegenerative Disorders and Its Inhibition Using Nonpeptidyl Natural Compounds
  80. Interaction of Glucagon G-Protein Coupled Receptor with Known Natural Antidiabetic Compounds: MultiscoringIn SilicoApproach
  81. Identification of Potent Caspase-3 Inhibitors for Treatment of Multi- Neurodegenerative Diseases Using Pharmacophore Modeling and Docking Approaches
  82. Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe3+: Its potential role in prompt recognition of diabetes mellitus auto-antibodies
  83. Molecular Interaction of Acetylcholinesterase with Carnosic Acid Derivatives: A Neuroinformatics Study
  84. Structure based molecular inhibition of Caspase-8 for treatment of multi-neurodegenerative diseases using known natural compounds
  85. Protease characteristics of bacteriocin producing Lysinibacilli, isolated from fruits and vegetable waste
  86. Drug Discovery and In Silico Techniques: A Mini-Review
  87. Predicted binding of certain antifilarial compounds with glutathione-S-transferase of human Filariids
  88. Mapping and analysis of the LINE and SINE type of repetitive elements in rice